Howard (Jack)L.WestMD

Oncology • Duarte, CA

Thoracic Cancer

Physician

Join to view full profile

Dr. West is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. West's full profile

Already have an account?

Office
1500 Duarte Rd
Duarte, CA 91010
Phone+1 626-256-4673

Fax+1 844-801-7368

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1998 - 2002
Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 1998
Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
Harvard Medical SchoolClass of 1996
University of CambridgeM Phil, Experimental Biology, 1990 - 1991

Certifications & Licensure

CA State Medical License 2012 - 2026
NV State Medical License 2022 - 2025
TX State Medical License 2012 - 2025
AK State Medical License 2022 - 2024
ID State Medical License 2022 - 2024
WA State Medical License 1998 - 2024
WY State Medical License 2022 - 2024
ME State Medical License 2020 - 2022
HI State Medical License 2012 - 2016
MA State Medical License 1998 - 2015
NY State Medical License 2012 - 2015
AZ State Medical License 2012 - 2014
FL State Medical License 2012 - 2014
IL State Medical License 2012 - 2014
PA State Medical License 2012 - 2014
VA State Medical License 2012 - 2014
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Super Doctor SuperDoctors.com

Clinical Trials

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2001 Dec 01
Completed
Phase 2
Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01
Unknown status
Phase 1
Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 1, Phase 2
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer Start of enrollment: 2005 Feb 01
Terminated
Phase 2
Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma Start of enrollment: 2007 Jan 01
Completed
Phase 2
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 2
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma Start of enrollment: 2007 Mar 01
Completed
Phase 2
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

990 citations
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-...
Howard Jack West, Michael McCleod, Maen A. Hussein, Alessandro Morabito, Achim Rittmeyer
The Lancet. Oncology. 2019-07-01
65 citations
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy inmutated non-small cell lung cancer with,orcomutations: subgroup results from the phase III IMpowe...
Howard Jack West, Mark McCleland, Federico Cappuzzo, Martin Reck, Tony Sk Mok
Journal for Immunotherapy of Cancer. 2022-02-01
448 citations
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Alice T. Shaw, Leena Gandhi, Shirish M. Gadgeel, Gregory J. Riely, Jeremy Cetnar
The Lancet. Oncology. 2016-02-01

External Links

Global Resource for Advancing Cancer Researchhttp://cancerGRACE.org